血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究

doi:10.3969/j.issn.1000-8535.2018.04.004

广州医药 ›› 2018, Vol. 49 ›› Issue (4): 13-16.DOI: 10.3969/j.issn.1000-8535.2018.04.004

血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究

银孟卓, 卢建文

广州市第一人民医院(广州 510180)

收稿日期:2018-02-27 出版日期:2018-07-20 发布日期:2021-11-29

Relationship between plasma chemerin levels and the permanent atrial fibrillation in patients with hypertension

YIN Mengzhuo, LU Jianwen

Guangzhou First People's Hospital, Guangzhou 510180, China

Received:2018-02-27 Online:2018-07-20 Published:2021-11-29

摘要/Abstract

摘要： 目的本研究旨在探讨血浆chemerin水平与原发性高血压合并心房颤动的相关性。方法选择2016年2月—2017年12月期间在广州市第一人民医院心内科及老年心内科住院的高血压患者160例,根据是否合并心房纤颤分为心房纤颤组(AF组,n=72)及非心房纤颤组(NAF组,n=88),另选取140例我院体检中心体检结果正常的正常健康人作为对照组(CON组,n=140)。采用全自动生化检测仪测定甘油三脂、总胆固醇、低密度脂蛋白、C反应蛋白等生化学指标;使用ELISA法检测血浆chemerin水平。结果 AF组患者的血浆chemerin水平较NAF组患者升高[(180.45±15.23)ng/mL vs(162.36±13.44)ng/mL,P<0.05],且均较CON组升高[(142.36±11.83)ng/mL,P<0.05)],多元Logistic回归分析显示血浆chemerin水平与高血压病合并心房纤颤呈独立相关性(OR 1.112, 95% CI 1.023～1.302;P<0.001)。结论高血浆chemerin水平可能是预测高血压合并心房纤颤的独立危险因素,血清chemerin可能成为一种预测高血压发生心房纤颤的重要生物学标记物。

关键词: chemerin, 心房颤动, 高血压

Abstract: Objective To explore the relationship between chemerin levels and permanent atrial fibrillation in patients with hypertension. Methods A total of 160 patients with hypertension were enrolled in this study. All the patients were classified as AF(n=72) or NAF(n=88) based on the permanent atrial fibrillation or not. And 140 healthy people were collected as a control group(CON). Triglycerides, total cholesterol, low density lipoprotein cholesterol and C-reactive protein were measured by automatic biochemical detector. Serum chemerin levels were determined by enzyme-linked immunosorbent assay(ELISA). Results Serum chemerin levels were higher in AF patients than those in NAF patients(180.45±15.23 ng/mL vs 162.36±13.44 ng/mL,P<0.05). They were both higher than that of the CON patients(142.36±11.83 ng/mL,P<0.05). Multivariate logistic regression demonstrated that chemerin level was independently associated with the permanent atrial fibrillation in patients with hypertension(OR 1.112, 95% CI 1.023～1.302;P<0.001). Conclusion Serum chemerin is an independent risk factor for permanent atrial fibrillation with hypertension. The results suggest that chemerin might be a useful biomarker for predicting the permanent atrial fibrillation with hypertension.

Key words: Chemerin, Atrial fibrillation, Hypertension

银孟卓, 卢建文. 血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究[J]. 广州医药, 2018, 49(4): 13-16.

YIN Mengzhuo, LU Jianwen. Relationship between plasma chemerin levels and the permanent atrial fibrillation in patients with hypertension[J]. Guangzhou Medical Journal, 2018, 49(4): 13-16.

参考文献

[1] BOZAOGLU K, BOLTON K, MCMILLAN J,et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome[J]. Endocrinol, 2007,148(10):4687-4694.
[2] WENG C, SHEN Z, LI X, JIANG W,et al. Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism[J]. Am J Transl Res, 2017,9(6):3096-3104.
[3] SHIN SY,YONG HS,LIM H E,et al. Total and interatrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol,2011,22(6):647-655.
[4] FUKUI A, TAKAHASHI N, NAKADA C,et al. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation[J]. Circ Arrhythm Electrophysiol, 2013,6(2):402-409.
[5] LANDSBERG L, ARONNE L J, BEILIN L J,et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment——a position paper of the The Obesity Society and The American Society of Hypertension[J]. Obesity (Silver Spring), 2013,21(1):8-24.
[6] SHIN H Y, LEE D C, CHU S H, et al. Chemerin levels are positively correlated with abdominal visceral fat accumulation[J]. Clin Endocrinol (Oxf), 2012,77(1):47-50.
[7] GU P, JIANG W, LU B, et al. Chemerin is associated with inflammatory makers and metabolic syndrome phenotypes in hypertension patients[J]. Clin Exp Hypertens, 2014,36(5): 326-332.
[8] WATTS S W, DORRANCE A M, PENFOLD M E, et al. Chemerin connects fat to arterial contraction[J]. Arterioscler Thromb Vasc Biol, 2013,33(6):1320-1328.
[9] BOBBERT T, SCHWARZ F, FISCHER-ROSINSKY A,et al. Chemerin and prediction of diabetes mellitus type 2[J]. Clin Endocrinol (Oxf), 2015,82(6):838-843.
[10] THACKER E L, MCKNIGHT B, PSATY B M,et al. Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation[J]. J Gen Intern Med, 2013,28(2):247-253.
[11] GAMI A S, HODGE D O, HERGES R M,et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation[J]. J Am Coll Cardiol, 2007,49(5):565-571.
[12] HARADA M, van WAGONER D R, NATTEL S. Role of inflammation in atrial fibrillation pathophysiology and management[J]. Circ J, 2015,79(3):495-502.
[13] ERNST M C, SINAL C J. Chemerin: at the crossroads of inflammation and obesity[J]. Trends Endocrinol Metab, 2010,21(11):660-667.

血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究

Relationship between plasma chemerin levels and the permanent atrial fibrillation in patients with hypertension

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	何同林, 何兰, 刘俊, 刘俊华, 阮宪东, 朱艳红. 高通量透析模式对改善维持性血液透析患者β2微球蛋白清除率及高血压的影响[J]. 广州医药, 2021, 52(5): 35-39.
[2]	汪秀衡, 刘克皝, 刘垚, 胡恒境. I¹³¹联合TSH抑制治疗对术后中高危组甲状腺乳头状癌患者心肌纤维化及心房颤动的影响[J]. 广州医药, 2021, 52(4): 40-44.
[3]	陈露丝, 岳晓军, 李韶南, 陈平安, 冯开薇, 吕何锦, 刘震. 社区综合防治合作模式对基层高血压病患者的药物经济学评价[J]. 广州医药, 2018, 49(4): 24-29.